| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Revenues | 376,572 | |||
| Cost of revenues | 185,570 | |||
| Research and development expenses | 80,285 | |||
| Selling, general and administrative expenses | 246,976 | |||
| Restructuring and other costs | 0 | |||
| Change in fair value of contingent considerations and holdbacks | 0 | |||
| Impairment of long-lived assets | 0 | |||
| Total costs and expenses | 512,831 | |||
| Loss from operations | -136,259 | |||
| Gain on sale of business | 48,847 | |||
| Interest income | 11,364 | |||
| Other income (expense), net | -903 | |||
| Loss before income taxes | -76,951 | |||
| Income tax expense | 719 | |||
| Net loss attributable to common stockholders | -77,670 | |||
| Change in unrealized gain (loss) on investments | -50 | |||
| Foreign currency translation adjustment | -55 | |||
| Comprehensive loss | -77,775 | |||
| Net loss per share attributable to common stockholdersbasic (in dollars per share) | -1.3 | |||
| Net loss per share attributable to common stockholdersdiluted (in dollars per share) | -1.3 | |||
| Weighted average shares used in computing net loss per share attributable to common stockholdersbasic (in shares) | 59,808,000 | |||
| Weighted average shares used in computing net loss per share attributable to common stockholdersdiluted (in shares) | 59,808,000 | |||
Twist Bioscience Corp (TWST)
Twist Bioscience Corp (TWST)